Download PDF
Am J Perinatol 2013; 30(02): 113-120
DOI: 10.1055/s-0032-1332802
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Maternal and Neonatal Herpes Simplex Virus Infections

Swetha G. Pinninti
1   Division of Pediatric Infectious Diseases, The University of Alabama, Birmingham, Alabama
,
David W. Kimberlin
1   Division of Pediatric Infectious Diseases, The University of Alabama, Birmingham, Alabama
› Author Affiliations
Further Information

Publication History

11 August 2012

10 October 2012

Publication Date:
09 January 2013 (online)

Also available at
    Permissions and Reprints

Abstract

Genital herpes infections are extremely common worldwide and ∼22% of pregnant women are infected with herpes simplex virus. Eighty percent of those affected with genital herpes are unaware of being infected. The most devastating consequence of maternal genital herpes is neonatal herpes disease. Fortunately, neonatal herpes simplex infections are uncommon but due to the morbidity and mortality associated with the infection are often considered in the differential diagnosis of ill neonates. The use of polymerase chain reaction assay for diagnosis of central nervous system infections and the development of safe and effective antiviral therapy have revolutionized the diagnosis and management of these infants. Most recently, the initiation of long-term antiviral suppressive therapy in these infants has led to significant improvement in morbidity. This review will summarize the epidemiology of maternal and neonatal herpes infections and discuss clinical presentation, diagnosis, management, and follow-up of infants with neonatal herpes disease.

Keywords

genital herpes - neonatal herpes - acyclovir - PCR - antiviral therapy
 

  • References

  • 1 Centers for Disease Control and Prevention (CDC). Seroprevalence of herpes simplex virus type 2 among persons aged 14–49 years—United States, 2005–2008. MMWR Morb Mortal Wkly Rep 2010; 59: 456-459
    PubMedSearch in Google Scholar
  • 2 Fleming DT, McQuillan GM, Johnson RE , et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997; 337: 1105-1111
    CrossrefPubMedSearch in Google Scholar
  • 3 Bryson Y, Dillon M, Bernstein DI, Radolf J, Zakowski P, Garratty E. Risk of acquisition of genital herpes simplex virus type 2 in sex partners of persons with genital herpes: a prospective couple study. J Infect Dis 1993; 167: 942-946
    CrossrefPubMedSearch in Google Scholar
  • 4 Ashley RL, Wald A. Genital herpes: review of the epidemic and potential use of type-specific serology. Clin Microbiol Rev 1999; 12: 1-8
    PubMedSearch in Google Scholar
  • 5 Johnson RE, Nahmias AJ, Magder LS, Lee FK, Brooks CA, Snowden CB. A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States. N Engl J Med 1989; 321: 7-12
    CrossrefPubMedSearch in Google Scholar
  • 6 Mertz GJ, Schmidt O, Jourden JL , et al. Frequency of acquisition of first-episode genital infection with herpes simplex virus from symptomatic and asymptomatic source contacts. Sex Transm Dis 1985; 12: 33-39
    PubMedSearch in Google Scholar
  • 7 Mertz GJ, Coombs RW, Ashley R , et al. Transmission of genital herpes in couples with one symptomatic and one asymptomatic partner: a prospective study. J Infect Dis 1988; 157: 1169-1177
    CrossrefPubMedSearch in Google Scholar
  • 8 Mertz GJ, Benedetti J, Ashley R, Selke SA, Corey L. Risk factors for the sexual transmission of genital herpes. Ann Intern Med 1992; 116: 197-202
    CrossrefPubMedSearch in Google Scholar
  • 9 Langenberg AG, Corey L, Ashley RL, Leong WP, Straus SE. Chiron HSV Vaccine Study Group. A prospective study of new infections with herpes simplex virus type 1 and type 2. N Engl J Med 1999; 341: 1432-1438
    CrossrefPubMedSearch in Google Scholar
  • 10 Wald A, Zeh J, Selke S , et al. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med 2000; 342: 844-850
    CrossrefPubMedSearch in Google Scholar
  • 11 Fife KH, Bernstein DI, Tu W , et al. Predictors of herpes simplex virus type 2 antibody positivity among persons with no history of genital herpes. Sex Transm Dis 2004; 31: 676-681
    PubMedSearch in Google Scholar
  • 12 Lafferty WE, Downey L, Celum C, Wald A. Herpes simplex virus type 1 as a cause of genital herpes: impact on surveillance and prevention. J Infect Dis 2000; 181: 1454-1457
    CrossrefPubMedSearch in Google Scholar
  • 13 Roberts CM, Pfister JR, Spear SJ. Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students. Sex Transm Dis 2003; 30: 797-800
    CrossrefPubMedSearch in Google Scholar
  • 14 Kimberlin DW, Rouse DJ. Clinical practice. Genital herpes. N Engl J Med 2004; 350: 1970-1977
    CrossrefPubMedSearch in Google Scholar
  • 15 Engelberg R, Carrell D, Krantz E, Corey L, Wald A. Natural history of genital herpes simplex virus type 1 infection. Sex Transm Dis 2003; 30: 174-177
    CrossrefPubMedSearch in Google Scholar
  • 16 Kulhanjian JA, Soroush V, Au DS , et al. Identification of women at unsuspected risk of primary infection with herpes simplex virus type 2 during pregnancy. N Engl J Med 1992; 326: 916-920
    CrossrefPubMedSearch in Google Scholar
  • 17 Brown ZA, Selke S, Zeh J , et al. The acquisition of herpes simplex virus during pregnancy. N Engl J Med 1997; 337: 509-515
    CrossrefPubMedSearch in Google Scholar
  • 18 Whitley RJ, Nahmias AJ, Visintine AM, Fleming CL, Alford CA. The natural history of herpes simplex virus infection of mother and newborn. Pediatrics 1980; 66: 489-494
    PubMedSearch in Google Scholar
  • 19 Whitley RJ, Corey L, Arvin A , et al. Changing presentation of herpes simplex virus infection in neonates. J Infect Dis 1988; 158: 109-116
    CrossrefPubMedSearch in Google Scholar
  • 20 Brown ZA, Benedetti J, Ashley R , et al. Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N Engl J Med 1991; 324: 1247-1252
    CrossrefPubMedSearch in Google Scholar
  • 21 Arvin AM, Hensleigh PA, Prober CG , et al. Failure of antepartum maternal cultures to predict the infant's risk of exposure to herpes simplex virus at delivery. N Engl J Med 1986; 315: 796-800
    CrossrefPubMedSearch in Google Scholar
  • 22 Vontver LA, Hickok DE, Brown Z, Reid L, Corey L. Recurrent genital herpes simplex virus infection in pregnancy: infant outcome and frequency of asymptomatic recurrences. Am J Obstet Gynecol 1982; 143: 75-84
    PubMedSearch in Google Scholar
  • 23 Workowski KA, Berman S. Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 2010; 59 (RR-12) 1-110
    PubMedSearch in Google Scholar
  • 24 Sullender WM, Yasukawa LL, Schwartz M , et al. Type-specific antibodies to herpes simplex virus type 2 (HSV-2) glycoprotein G in pregnant women, infants exposed to maternal HSV-2 infection at delivery, and infants with neonatal herpes. J Infect Dis 1988; 157: 164-171
    CrossrefPubMedSearch in Google Scholar
  • 25 ACOG Committee on Practice Bulletins. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. No. 82 June 2007. Management of herpes in pregnancy. Obstet Gynecol 2007; 109: 1489-1498
    CrossrefPubMedSearch in Google Scholar
  • 26 Brown ZA, Wald A, Morrow RA, Selke S, Zeh J, Corey L. Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA 2003; 289: 203-209
    CrossrefPubMedSearch in Google Scholar
  • 27 Kimberlin DW. Neonatal herpes simplex infection. Clin Microbiol Rev 2004; 17: 1-13
    CrossrefPubMedSearch in Google Scholar
  • 28 Corey L, Wald A. Maternal and neonatal herpes simplex virus infections. N Engl J Med 2009; 361: 1376-1385
    CrossrefPubMedSearch in Google Scholar
  • 29 Nahmias AJ, Josey WE, Naib ZM, Freeman MG, Fernandez RJ, Wheeler JH. Perinatal risk associated with maternal genital herpes simplex virus infection. Am J Obstet Gynecol 1971; 110: 825-837
    PubMedSearch in Google Scholar
  • 30 Prober CG, Sullender WM, Yasukawa LL, Au DS, Yeager AS, Arvin AM. Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes simplex virus infections. N Engl J Med 1987; 316: 240-244
    CrossrefPubMedSearch in Google Scholar
  • 31 Yeager AS, Arvin AM. Reasons for the absence of a history of recurrent genital infections in mothers of neonates infected with herpes simplex virus. Pediatrics 1984; 73: 188-193
    PubMedSearch in Google Scholar
  • 32 Peng J, Krause PJ, Kresch M. Neonatal herpes simplex virus infection after cesarean section with intact amniotic membranes. J Perinatol 1996; 16: 397-399
    PubMedSearch in Google Scholar
  • 33 O'Riordan DP, Golden WC, Aucott SW. Herpes simplex virus infections in preterm infants. Pediatrics 2006; 118: e1612-e1620
    CrossrefPubMedSearch in Google Scholar
  • 34 Overall Jr JC. Herpes simplex virus infection of the fetus and newborn. Pediatr Ann 1994; 23: 131-136
    PubMedSearch in Google Scholar
  • 35 Whitley RJ, Nahmias AJ, Soong SJ, Galasso GG, Fleming CL, Alford CA. Vidarabine therapy of neonatal herpes simplex virus infection. Pediatrics 1980; 66: 495-501
    PubMedSearch in Google Scholar
  • 36 Whitley R, Arvin A, Prober C , et al; Infectious Diseases Collaborative Antiviral Study Group. A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. N Engl J Med 1991; 324: 444-449
    CrossrefPubMedSearch in Google Scholar
  • 37 Whitley R, Arvin A, Prober C , et al; The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Predictors of morbidity and mortality in neonates with herpes simplex virus infections. N Engl J Med 1991; 324: 450-454
    CrossrefPubMedSearch in Google Scholar
  • 38 Kimberlin DW, Lin CY, Jacobs RF , et al; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics 2001; 108: 230-238
    CrossrefPubMedSearch in Google Scholar
  • 39 Kimberlin DW, Lin CY, Jacobs RF , et al; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics 2001; 108: 223-229
    CrossrefPubMedSearch in Google Scholar
  • 40 Arvin AM, Yeager AS, Bruhn FW, Grossman M. Neonatal herpes simplex infection in the absence of mucocutaneous lesions. J Pediatr 1982; 100: 715-721
    PubMedSearch in Google Scholar
  • 41 Pickering L, Baker C, Kimberlin D. In: Pickering L, , ed. Red Book Report of the Committee on Infectious Diseases. 29th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2012: 398-408
  • 42 Barbi M, Binda S, Primache V, Tettamanti A, Negri C, Brambilla C. Use of Guthrie cards for the early diagnosis of neonatal herpes simplex virus disease. Pediatr Infect Dis J 1998; 17: 251-252
    PubMedSearch in Google Scholar
  • 43 Diamond C, Mohan K, Hobson A, Frenkel L, Corey L. Viremia in neonatal herpes simplex virus infections. Pediatr Infect Dis J 1999; 18: 487-489
    PubMedSearch in Google Scholar
  • 44 Kimberlin DW, Lakeman FD, Arvin AM , et al; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease. J Infect Dis 1996; 174: 1162-1167
    CrossrefPubMedSearch in Google Scholar
  • 45 Malm G, Forsgren M. Neonatal herpes simplex virus infections: HSV DNA in cerebrospinal fluid and serum. Arch Dis Child Fetal Neonatal Ed 1999; 81: F24-F29
    CrossrefPubMedSearch in Google Scholar
  • 46 Atkins JT. HSV PCR for CNS infections: pearls and pitfalls. Pediatr Infect Dis J 1999; 18: 823-824
    PubMedSearch in Google Scholar
  • 47 Kimura H, Futamura M, Kito H , et al. Detection of viral DNA in neonatal herpes simplex virus infections: frequent and prolonged presence in serum and cerebrospinal fluid. J Infect Dis 1991; 164: 289-293
    CrossrefPubMedSearch in Google Scholar
  • 48 Troendle-Atkins J, Demmler GJ, Buffone GJ. Rapid diagnosis of herpes simplex virus encephalitis by using the polymerase chain reaction. J Pediatr 1993; 123: 376-380
    PubMedSearch in Google Scholar
  • 49 Englund JA, Fletcher CV, Balfour Jr HH. Acyclovir therapy in neonates. J Pediatr 1991; 119 (1 Pt 1) 129-135
    PubMedSearch in Google Scholar
  • 50 Caviness AC, Demmler GJ, Almendarez Y, Selwyn BJ. The prevalence of neonatal herpes simplex virus infection compared with serious bacterial illness in hospitalized neonates. J Pediatr 2008; 153: 164-169
    PubMedSearch in Google Scholar
  • 51 Kimberlin DW. When should you initiate acyclovir therapy in a neonate?. J Pediatr 2008; 153: 155-156
    PubMedSearch in Google Scholar
  • 52 Long SS. In defense of empiric acyclovir therapy in certain neonates. J Pediatr 2008; 153: 157-158
    PubMedSearch in Google Scholar
  • 53 Kimberlin DW, Whitley RJ, Wan W , et al; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Oral acyclovir suppression and neurodevelopment after neonatal herpes. N Engl J Med 2011; 365: 1284-1292
    CrossrefPubMedSearch in Google Scholar
  • 54 Kimberlin D, Powell D, Gruber W , et al. Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a phase I/II trial. Pediatr Infect Dis J 1996; 15: 247-254
    PubMedSearch in Google Scholar
  • 55 Kimberlin DW, Jacobs RF, Weller S , et al. Pharmacokinetics and safety of extemporaneously compounded valacyclovir oral suspension in pediatric patients from 1 month through 11 years of age. Clin Infect Dis 2010; 50: 221-228
    CrossrefPubMedSearch in Google Scholar
  • 56 Pinninti SG, Angara R, Feja KN , et al. Neonatal herpes disease following maternal antenatal antiviral suppressive therapy: a multicenter case series. J Pediatr 2012; 161: 134-138 , e1–e3
    CrossrefPubMedSearch in Google Scholar
  • 57 Stanberry LR, Spruance SL, Cunningham AL , et al; GlaxoSmithKline Herpes Vaccine Efficacy Study Group. Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N Engl J Med 2002; 347: 1652-1661
    CrossrefPubMedSearch in Google Scholar
  • 58 Belshe RB, Leone PA, Bernstein DI , et al; Herpevac Trial for Women. Efficacy results of a trial of a herpes simplex vaccine. N Engl J Med 2012; 366: 34-43
    CrossrefPubMedSearch in Google Scholar
  • 59 Whitley RJ, Kimberlin DW. Treatment of viral infections during pregnancy and the neonatal period. Clin Perinatol 1997; 24: 267-283
    PubMedSearch in Google Scholar